Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Viatris Inc. - Common Stock (NQ:VTRS)

13.12 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Jan 27, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Viatris Inc. - Common Stock

< Previous 1 2
...
14 15 16 17 18 19 20 21 Next >
News headline image
Viatris Inc (VTRS) Q2 2021 Earnings Call Transcript ↗
VTRS earnings call for the period ending June 30, 2021. 
Via The Motley Fool
Topics Earnings
Unusual Options Activity Insight: Viatris ↗
On Monday, shares of Viatris (NASDAQ:VTRS) saw unusual opt... 
Via Benzinga
News headline image
How This Historic FDA Approval Benefits Viatris ↗
Here's what the FDA's approval of Semglee, from Viatris and Biocon, means for the former. 
Via The Motley Fool
News headline image
Viatris Stock Gains After FDA Approves Viatris-Biocon Biologics' Insulin Glargine Biosimilar Injection ↗
The FDA cleared Viatris inc (NASDAQ: VTRS) - Biocon Biologics' Semglee insulin glargine-yfgn injection as a biosimilar. Semglee indicates controlling high... 
Via Benzinga
News headline image
How To Find Value Stocks July 2021 ↗
Identifying fair value in an inflated stock market is really important, because in all markets, whether bull or bear you can always find value. 
Via Talk Markets
News headline image
10 Worst Performing S&P 500 Stocks Of 2021 ↗
The S&P 500 has continued its late-2020 momentum in the first two quarters of the year, gaining more than 15% year-to-date. Most U.S. investors have had a lot of winners in... 
Via Benzinga
Topics Stocks
News headline image
Earnings Scheduled For May 10, 2021 ↗
Companies Reporting Before The Bell • Revlon (NYSE:REV) is likely to report earnings for its first quarter. • Bluegreen Vacations (NYSE:BVH) is expected to report... 
Via Benzinga
News headline image
Earnings Scheduled For August 9, 2021 ↗
Companies Reporting Before The Bell • Privia Health Group (NASDAQ:PRVA) is projected to report quarterly loss at $1.57 per share on revenue of $215.17 million. •... 
Via Benzinga
News headline image
The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight ↗
Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Merck's Disappointing Q2, Atreca Falls On Data, FDA Nod For Viatris, Nuvalent, Icosavax IPOs ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 28) AbbVie Inc. (NYSE: ABBV)... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Lilly Spikes On Alzheimer's Drug Regulatory Filing Plan, Applied Genetics, Arcus Issue Data Readouts, Adcom Test Awaits Incyte, Monte Rosa Prices IPO ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 23) AngioDynamics, Inc. (NASDAQ... 
Via Benzinga
News headline image
Why Viatris Stock Rocketed Higher in May ↗
This undervalued dividend stock finally found its footing in May. 
Via The Motley Fool
News headline image
2 Best Value Stocks to Buy Now ↗
Looking for solid companies trading on the cheap? Here are your top bets! 
Via The Motley Fool
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For June 15, 2021 ↗
Upgrades According to Raymond James, the prior rating for Welltower Inc (NYSE:WELL) was changed from Market Perform to Strong Buy. For the first quarter, Welltower had an... 
Via Benzinga
News headline image
2 Healthcare Stocks That Could Be Millionaire-Makers ↗
The combination of stability and innovation makes these giants safe bets for long-term returns. 
Via The Motley Fool
News headline image
Is Viatris a Good Stock to Buy for 2021? ↗
Long-term investors might want to consider adding this recently formed pharmaceutical company to their portfolios. 
Via The Motley Fool
News headline image
Why Is No One Talking About Viatris Stock? ↗
This company is one of the largest manufacturers of generic pharmaceuticals in the world, but it may be underpriced. 
Via The Motley Fool
News headline image
Not Just GameStop, WallStreetBets' Target Melvin Capital Closed All Public Short Positions In Q1 ↗
Hedge fund Melvin Capital Management LP, which was at the heart of the GameStop Corp. (NYSE: GME) short squeeze frenzy earlier this year, closed out of all its public short... 
Via Benzinga
News headline image
Viatris Inc (VTRS) Q1 2021 Earnings Call Transcript ↗
VTRS earnings call for the period ending March 31, 2021. 
Via The Motley Fool
Topics Earnings
News headline image
Viatris Q1 Sales Tops Estimates, Reaffirms 2021 Outlook, Announces Quarterly Dividend ↗
Viatris Inc (NASDAQ: VTRS) reported Q1 net sales of $4.4 billion, down 6% Y/Y on a reported basis, but only down 2% compared to a combined loss of exclusivity... 
Via Benzinga
News headline image
Is Generic-Drug Maker Viatris a Keeper? ↗
It depends on what type of investor you are. 
Via The Motley Fool
News headline image
Cramer Shares His Thoughts On JetBlue, General Electric And More ↗
On CNBC's "Mad Money Lightning Round," Jim Cramer said he is an EV guy, but you have got to pick which EV you want. He prefers Tesla, Inc. (NASDAQ: TSLA) over... 
Via Benzinga
News headline image
Wall Street Thinks This Dirt-Cheap Stock Will Soar 50% ↗
But that's not the best reason to consider buying it. 
Via The Motley Fool
News headline image
3 Best Value Stocks to Buy Now ↗
On the hunt for bargains in today's overvalued market? Look no further. 
Via The Motley Fool
News headline image
Warning: S&P 500 A Lost Decade Is Coming ↗
The S&P 500 index is entering a potential lost decade. However, it is a market of stocks and not a stock market. 
Via Talk Markets
Topics Stocks
News headline image
The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings ↗
Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came... 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Tuesday ↗
Tuesday morning, 38 companies set new 52-week lows. Key Facts: Viatris (NASDAQ:VTRS) was the largest company by market cap to set a new 52-week low. Enservco (AMEX:... 
Via Benzinga
News headline image
Pfizer's About to Cut Its Dividend: What You Need to Know ↗
The big drugmaker's dividend won't remain at its current level for much longer. 
Via The Motley Fool
News headline image
Better Value Stock: AbbVie or Viatris? ↗
Look at more than just the valuation metrics. 
Via The Motley Fool
News headline image
Stocks That Hit 52-Week Lows On Thursday ↗
On Thursday morning, 6 companies achieved new lows for the year. Areas of Significance: Viatris (NASDAQ:VTRS) was the largest, in terms of market cap, to set a new... 
Via Benzinga
< Previous 1 2
...
14 15 16 17 18 19 20 21 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.